✦ LIBER ✦

THE MAGNITUDE OF CARDIOVASCULAR CHANGE IN CIRRHOTIC CARDIOMYOPATHY IN PREDICTING OF HEPATORENAL SYNDROME

✍ Scribed by Junpaparp, Parichart; Purushottam, Bhaskar; Buppajarntham, Saranya; Pomerantz, Sherry; Figueredo, Vincent

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(112). Frequency and predictive factors

✍ M. Fekih; H. Romdhane; L. Kallel; S. Matri; S. Karoui; J. Boubaker; A. Filali 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 39 KB

Octreotide in the treatment of the hepat

✍ Frédéric Kaffy; Catherine Borderie; Carine Chagneau; Marie Pierre Ripault; Isabe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 86 KB

P932 CIRRHOTIC CARDIOMYOPATHY MANIFESTED

✍ Zaidi, Y.A.; Ali, B.; Salim, A.; Adil, M.; Alam, A.; Butt, A.K.; Malik, K.; Amin 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 106 KB

113 CIRRHOTIC CARDIOMYOPATHY MANIFESTED

✍ L. Achécar; A. González-Tallón; F. Mesonero; J. Pérez-Lasala; M. Tejedor; R. Ser 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Promising long-term efficacy of palliati

✍ Brensing, KA; Textor, J; Perz, J; Schiedermaier, P; Raab, P; Strunk, H; Klehr, H 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Efficacy and safety of terlipressin in c

✍ Aleksander Krag; Tine Borup; Søren Møller; Flemming Bendtsen 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 559 KB